Molekulardiagnostik

PHOENIXDX® SARS-COV-2 MULTIPLEX IVD ist ein in-vitro Diagnostik Test zum Nachweis viraler 2019- Novel Coronavirus (SARS-CoV-2) RNA aus Proben aus dem Respirationstrakt von Patienten, die den klinischen und/oder epidemiologischen Kriterien entsprechen.

PHOENIXDX® COFLUENZA 4-PLEX IVD is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of Influenza A, Influenza B and SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [N501Y] is a real-time RT-PCR-based diagnostic test for the in vitro discrimination between wildtype SARS-CoV-2 and N501Y mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 IVD is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of 2019-Novel Coronavirus (SARS-CoV-2) in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.

Genvinset® Lactose Intolerance is a semi-automated in vitro diagnostic kit for the qualitative detection of the polymorphisms -13910 C/T (NCBI dbSNP rs4988235; NM_005915.6: c.1917+326C>T) and -22018 G/A (NCBI dbSNP rs182549; NM_005915.5: c.1362+117G>A) of the MCM6 gene (OMIM: 601806) associated with lactase persistence, in genomic DNA extracted from whole blood, by Real Time PCR using specific TaqMan® probes technology.

Genvinset® PAI-1 4G/5G is a kit for the in vitro qualitative detection of the 4G/5G deletion (NCBI dbSNP rs1799762; NM_000602.5:c.-820G[(4_5)]) in the promoter region of the Plasminogen activator inhibitor 1 (SERPINE1) gene (OMIM: 173360) associated with thrombophilia risk, in genomic DNA extracted from whole blood using Real Time PCR technology with specific TaqMan® probes.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [D614G] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and D614G mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [DEL HV69/70] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and del HV69/70 mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [E484K] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and E484K mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [E484Q] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and E484Q mutant SARS-CoV-2 in respiratory specimens and sera.